ES|EN
Skip to content
se habla de ...

Translating absolute breast cancer risk into how often to screen

PET/MRI changes the treatment plan in almost one third of early breast cancers

Miami reviews the controversies in breast cancer treatment in March

Mammography beyond five years does not prevent advanced tumours in older survivors

Breast units and tumour boards: rethinking the organisational model

A symptom-tracking app lowers the cost of follow-up during adjuvant hormone therapy

Five-year results of PET-guided de-escalation in HER2-positive breast cancer

Specimen ultrasound matches mammography for margin assessment in breast surgery

Delaying breast cancer surgery beyond 30 days is already linked to worse survival

Why antibody-drug conjugates stop working in HER2-low breast cancer

Mammography satisfaction hinges on communication and workflow, not clinical factors

Neoadjuvant chemotherapy makes residual HR+/HER2- tumours more radioresistant

Rapid-relapse triple-negative breast cancer: aggressive tumours and social disadvantage

Immunotherapy with radiotherapy in triple-negative breast cancer: more hypothyroidism

Accredited breast centres report fewer surgical complications

Four questionnaires for breast lymphoedema compared: BLYSS performs best

An oncoplastic team and a digital pathway raise breast conservation to 96%

Sac-TMT confirms its overall survival benefit in advanced triple-negative breast cancer

Young-onset breast cancer burden shifts from Europe to Asia-Pacific

A bispecific antibody doubles progression-free survival in pretreated HR+/HER2- breast cancer

Oncomama
Oncomama

Papers de oncología de mama y avances de las unidades de mama en España

  • Diagnosis
    • Prevention & Screening
    • Breast Units
  • Treatment
    • Surgery & Reconstruction
  • Research
    • Meetings
    • Bibliomama Library
opciones
  • Diagnosis
    • Prevention & Screening
    • Breast Units
  • Treatment
    • Surgery & Reconstruction
  • Research
    • Meetings
    • Bibliomama Library
  • Breast Units
  • Prevention & Screening

Translating absolute breast cancer risk into how often to screen

A risk-model-agnostic framework maps guideline absolute-risk cut points to mammography intervals, so that personalised screening speaks a common language....

oncomama
J Natl Cancer InstNovember 5, 2026
  • Breast Units
  • Diagnosis

PET/MRI changes the treatment plan in almost one third of early breast cancers

oncomama
Eur J CancerNovember 4, 2026
  • Meetings
  • Treatment

Miami reviews the controversies in breast cancer treatment in March

oncomama
MBCC 2027November 4, 2026
  • Diagnosis
  • Prevention & Screening

Mammography beyond five years does not prevent advanced tumours in older survivors

oncomama
JAMA Intern MedNovember 4, 2026
  • Breast Units

Breast units and tumour boards: rethinking the organisational model

oncomama
J Cancer PolicyNovember 3, 2026
A symptom-tracking app lowers the cost of follow-up during adjuvant hormone therapy
JAMA Netw OpenNovember 3, 2026
Five-year results of PET-guided de-escalation in HER2-positive breast cancer
Nat MedNovember 2, 2026
Specimen ultrasound matches mammography for margin assessment in breast surgery
Surg Pract SciNovember 2, 2026
Delaying breast cancer surgery beyond 30 days is already linked to worse survival
Ann Surg OncolNovember 1, 2026
Why antibody-drug conjugates stop working in HER2-low breast cancer
Oncol RepNovember 1, 2026
Mammography satisfaction hinges on communication and workflow, not clinical factors
Breast CareOctober 31, 2026
Copyright © 2026 | Powered by News Magazine X
oncomama  ·  oncohub  ·  disforia
Desarrollado por dosier.es y diseñado por marta ai